Literature DB >> 11413333

Herpes simplex virus type 1 latency-associated transcript gene promotes neuronal survival.

R L Thompson1, N M Sawtell.   

Abstract

A complex interaction has evolved between the host's peripheral nervous system (PNS) and herpes simplex virus type 1 (HSV-1). Sensory neurons are permissive for viral replication, yet the virus can also enter a latent state in these cells. The interplay of viral and neuronal signals that regulate the switch between the viral lytic and latent states is not understood. The latency-associated transcript (LAT) regulates the establishment of the latent state and is required for >65% of the latent infections established by HSV-1 (R. L. Thompson and N. M. Sawtell, J. Virol. 71:5432-5440, 1997). To further investigate how LAT functions, a 1.9-kb deletion that includes the entire LAT promoter and 827 bp of the 5' end of the primary LAT mRNA was introduced into strain 17syn+. The wild-type parent, three independently derived deletion mutants, and two independently derived genomically rescued variants of the mutants were analyzed in a mouse ocular model. The number of latent sites established in trigeminal ganglion (TG) neurons was determined using a single-cell quantitative PCR assay for the viral genome on purified TG neurons. It was found that the LAT null mutants established ~75% fewer latent infections than the number established by the parental strain or rescued variant. The reduced establishment phenotype of LAT null mutants was due at least in part to a dramatic increase in the loss of TG neurons in animals infected with the LAT mutants. Over half of the neurons in the TG were destroyed following infection with the LAT mutants, and this was significantly more than were lost following infection with wild type. This is the first demonstration that the HSV LAT locus prevents the destruction of sensory neurons. The death of these neurons did not appear to be the result of increased apoptosis as measured by a terminal deoxynucleotidyltransferase-mediated dUTP-biotin nick end labeling assay. Animals latently infected with the LAT null mutants reactivated less frequently in vivo and this was consistent with the reduction in the number of neurons in which latency was established. Thus, one function of the LAT gene is to protect sensory neurons and enhance the establishment of latency in the PNS.

Entities:  

Mesh:

Year:  2001        PMID: 11413333      PMCID: PMC114389          DOI: 10.1128/JVI.75.14.6660-6675.2001

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  87 in total

1.  A 348-base-pair region in the latency-associated transcript facilitates herpes simplex virus type 1 reactivation.

Authors:  D C Bloom; J M Hill; G Devi-Rao; E K Wagner; L T Feldman; J G Stevens
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

2.  The proportion of trigeminal ganglionic neurons expressing herpes simplex virus type 1 latency-associated transcripts correlates to reactivation in the New Zealand rabbit ocular model.

Authors:  Y J Gordon; E G Romanowski; T Araullo-Cruz; P R Kinchington
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1995-10       Impact factor: 3.117

3.  Quantification of transcripts from the ICP4 and thymidine kinase genes in mouse ganglia latently infected with herpes simplex virus.

Authors:  M F Kramer; D M Coen
Journal:  J Virol       Date:  1995-03       Impact factor: 5.103

4.  Analysis of a herpes simplex virus type 1 LAT mutant with a deletion between the putative promoter and the 5' end of the 2.0-kilobase transcript.

Authors:  J Maggioncalda; A Mehta; N W Fraser; T M Block
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

5.  The latency-associated transcript gene of herpes simplex virus type 1 (HSV-1) is required for efficient in vivo spontaneous reactivation of HSV-1 from latency.

Authors:  G C Perng; E C Dunkel; P A Geary; S M Slanina; H Ghiasi; R Kaiwar; A B Nesburn; S L Wechsler
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

6.  An avirulent ICP34.5 deletion mutant of herpes simplex virus type 1 is capable of in vivo spontaneous reactivation.

Authors:  G C Perng; R L Thompson; N M Sawtell; W E Taylor; S M Slanina; H Ghiasi; R Kaiwar; A B Nesburn; S L Wechsler
Journal:  J Virol       Date:  1995-05       Impact factor: 5.103

7.  The region of the herpes simplex virus type 1 LAT gene that is colinear with the ICP34.5 gene is not involved in spontaneous reactivation.

Authors:  G C Perng; K Chokephaibulkit; R L Thompson; N M Sawtell; S M Slanina; H Ghiasi; A B Nesburn; S L Wechsler
Journal:  J Virol       Date:  1996-01       Impact factor: 5.103

8.  A structural and functional comparison of the latency-associated transcript promoters of herpes simplex virus type 1 strains KOS and McKrae.

Authors:  L I Strelow; K A Laycock; P Y Jun; K A Rader; R H Brady; J K Miller; J S Pepose; D A Leib
Journal:  J Gen Virol       Date:  1994-09       Impact factor: 3.891

9.  In vivo deletion analysis of the herpes simplex virus type 1 latency-associated transcript promoter.

Authors:  A T Dobson; T P Margolis; W A Gomes; L T Feldman
Journal:  J Virol       Date:  1995-04       Impact factor: 5.103

10.  Two herpes simplex virus type 1 latency-active promoters differ in their contributions to latency-associated transcript expression during lytic and latent infections.

Authors:  X Chen; M C Schmidt; W F Goins; J C Glorioso
Journal:  J Virol       Date:  1995-12       Impact factor: 5.103

View more
  94 in total

1.  Regions of the herpes simplex virus type 1 latency-associated transcript that protect cells from apoptosis in vitro and protect neuronal cells in vivo.

Authors:  Maryam Ahmed; Martin Lock; Cathie G Miller; Nigel W Fraser
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

2.  The stable 2.0-kilobase intron of the herpes simplex virus type 1 latency-associated transcript does not function as an antisense repressor of ICP0 in nonneuronal cells.

Authors:  Edward A Burton; Chang-Sook Hong; Joseph C Glorioso
Journal:  J Virol       Date:  2003-03       Impact factor: 5.103

Review 3.  CD8+ T cells patrol HSV-1-infected trigeminal ganglia and prevent viral reactivation.

Authors:  Anthony J St Leger; Robert L Hendricks
Journal:  J Neurovirol       Date:  2011-12-08       Impact factor: 2.643

Review 4.  Herpes simplex virus latency-associated transcript gene function.

Authors:  Jennifer R Kent; Wen Kang; Cathie G Miller; Nigel W Fraser
Journal:  J Neurovirol       Date:  2003-06       Impact factor: 2.643

5.  Analysis of herpes simplex virus ICP0 promoter function in sensory neurons during acute infection, establishment of latency, and reactivation in vivo.

Authors:  R L Thompson; May T Shieh; N M Sawtell
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

6.  Wide variations in herpes simplex virus type 1 inoculum dose and latency-associated transcript expression phenotype do not alter the establishment of latency in the rabbit eye model.

Authors:  J E O'Neil; J M Loutsch; J S Aguilar; J M Hill; E K Wagner; D C Bloom
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

7.  Comparison of herpes simplex virus reactivation in ganglia in vivo and in explants demonstrates quantitative and qualitative differences.

Authors:  N M Sawtell; R L Thompson
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

Review 8.  Herpes simplex virus type 1 and Bell's palsy-a current assessment of the controversy.

Authors:  Peter Ge Kennedy
Journal:  J Neurovirol       Date:  2010-02       Impact factor: 2.643

9.  Clues to mechanisms of herpesviral latent infection and potential cures.

Authors:  David M Knipe; Priya Raja; Jennifer S Lee
Journal:  Proc Natl Acad Sci U S A       Date:  2015-09-21       Impact factor: 11.205

10.  Therapeutic implications of new insights into the critical role of VP16 in initiating the earliest stages of HSV reactivation from latency.

Authors:  Richard L Thompson; Nancy M Sawtell
Journal:  Future Med Chem       Date:  2010-07       Impact factor: 3.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.